Stokes 1987.
Methods | Generation of the allocation sequence: unclear (not reported). Allocation concealment: unclear (not reported). Blinding: yes ‐ adequately blinded with identical placebo. Follow‐up: Inadequate. Twelve weeks after treatment. The number or reasons for dropouts and withdrawals were not described. | |
Participants | Patients with non‐A, non‐B chronic hepatitis based on clinical criteria, negative hepatitis‐B serology, and compatible liver histology. | |
Interventions | Prednisone group:
all patients received 60 mg/day for two weeks followed by two weeks with 30 mg/day. Placebo group: all patients received identical placebo. |
|
Outcomes | ALT. | |
Notes | Only abstract. No information on health economics was provided. | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment? | Unclear risk | B ‐ Unclear |